Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 2/20 | 0.62 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.62 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.62 |
| ▸ | TACR1 | P25103 | 2/20 | 0.61 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.58 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.56 |
| ▸ | NPY1R | P25929 | 2/20 | 0.55 |
| ▸ | NPY2R | P49146 | 1/20 | 0.55 |
| ▸ | NPY4R | P50391 | 1/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.55 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.54 |
| ▸ | CTSB | P07858 | 2/20 | 0.54 |
| ▸ | GNRHR | P30968 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28202049 | 0.91 | CXCR4 (0.60) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| SCHEMBL29675079 | 0.91 | CXCR4 (0.60) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| Omiganan SCHEMBL27824120 | 0.89 | CXCR4 (0.60) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| Omiganan SCHEMBL29410943 | 0.89 | CXCR4 (0.59) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| SCHEMBL29674929 | 0.88 | CXCR4 (0.59) | OPRM1OPRK1CXCR4 | |
| SCHEMBL29675119 | 0.88 | CXCR4 (0.59) | OPRM1OPRK1CXCR4 | |
| SCHEMBL29412263 | 0.87 | CXCR4 (0.61) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| SCHEMBL30358622 | 0.86 | OPRD1 (0.61) | NTSR2NTSR1SORT1OPRD1OPRM1 | |
| SCHEMBL29716634 | 0.86 | NTSR2 (0.75) | NTSR2NTSR1SORT1TACR1OPRD1 | |
| SCHEMBL29535981 | 0.85 | TACR1 (0.78) | NTSR2NTSR1SORT1TACR1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4710943-A2 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | Molecular Transfer, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| WO-2026042045-A1 | INDOLICIDINE-CONTAINING COMPOSITIONS FOR PERSONAL CARE/HYGIENE APPLICATIONS | ITC LIMITED (IN) | 2026-02-26 | — | — | WO | claimed |
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | claimed |
| EP-4642761-A1 | BIOREACTIVE PROTEINS CONTAINING AN UNNATURAL AMINO ACID AND ARGININE | The Regents of University of California (US) | 2025-11-05 | — | — | EP | claimed |
| WO-2025106551-A1 | HYDROGEL COMPOSITIONS COMPRISING SYNERGISTIC ANTIMICROBIAL PEPTIDES (AMPS) AND METHODS OF MAKING SAME | ROWAN UNIVERSITY (US) | 2025-05-22 | — | — | WO | claimed |
| US-20250154525-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME | MOLECULAR TRANSFER, INC. | 2025-05-15 | — | — | US | claimed |
| WO-2025018943-A1 | BIODEGRADABLE POLYION COMPLEX NANOPARTICLES OF CATIONIC ANTIMICROBIALS FOR ACTIVATABLE ANTIBACTERIAL THERAPY | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-01-23 | — | — | WO | claimed |
| US-12171801-B2 | Compositions and related methods for controlling vector-borne diseases | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2024-12-24 | — | — | US | claimed |
| CN-119119300-A | Substrate composition for screening antibacterial peptide | 北京工商大学 | 2024-12-13 | — | — | CN | claimed |
| WO-2024184403-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR BIOME APS (DK) | 2024-09-12 | — | — | WO | claimed |
| CN-116953219-A | Fluorescent array sensor for multiple bacteria identification and detection method thereof | 南通大学 | 2023-10-27 | — | — | CN | claimed |
| US-20220348960-A1 | VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2022-11-03 | — | — | US | claimed |
| US-20220339187-A1 | ANTIMICROBIAL PEPTIDE-SELENIUM NANOPARTICLES | THE UNIVERSITY OF MELBOURNE (AU) | 2022-10-27 | — | — | US | claimed |
| WO-2022217071-A1 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2022-10-13 | — | — | WO | claimed |
| US-20220288183-A1 | VACCINE CONSTRUCTS AND USES THEREOF AGAINST STAPHYLOCOCCUS INFECTIONS | SOCPRA SCIENCES ET GENIE S.E.C. (CA) | 2022-09-15 | — | — | US | claimed |
| EP-3129044-B1 | PEPTIDOGLYCAN HYDROLASE FOR USE IN THE TREATMENT OF CHRONIC BACTERIAL INFECTIONS | LYSANDO AG (LI) | 2022-09-07 | — | — | EP | claimed |
| WO-2022174142-A1 | COMPOSITIONS AND METHODS FOR USING COMBINATIONS OF ACTIN-BASED PEPTIDES TO MODULATE CELLULAR BIOACTIVITY AND CELLULAR SUSCEPTIBILITY TO INTRACELLULAR PATHOGENS | Virongy L.L.C. (US) | 2022-08-18 | — | — | WO | claimed |
| CN-107661240-B | Submicron emulsion repair stock solution composition, preparation method thereof and cosmetic composition containing submicron emulsion repair stock solution composition | 山东千色生物科技有限公司 | 2022-05-31 | — | — | CN | claimed |
| US-11324815-B2 | Vaccine constructs and uses thereof against Staphylococcus infections | Socpra—Sciences et Genie, S.E.C. (CA) | 2022-05-10 | — | — | US | claimed |
| US-20220090141-A1 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | MOLECULAR TRANSFER, INC. | 2022-03-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154525-A1 | PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME | HDLBP, PHAX, PLTP | NTSR2 4812/4885NTSR1 4752/4885SORT1 514/4885 |
| US-20220090141-A1 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | TIAL1, NPC1L1, LIPA | NTSR2 4228/4885NTSR1 4195/4885SORT1 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.